Telmisartan, an Angiotensin II Type 1 Receptor Blocker, Improves Coronary Microcirculation and Insulin Resistance among Essential Hypertensive Patients without Left Ventricular Hypertrophy

Search this article

Journal

Citations (3)*help

See more

References(31)*help

See more

Details 詳細情報について

Report a problem

Back to top